The clinical relevance of the microbiome when managing paediatric infectious diseases-Narrative review

Talía Sainz1,2, Jaime Delgado1,2, Ana Mendez-Echevarría1,2

  • 1Hospital La Paz and La Paz Research Intitute (IdiPAZ), Madrid, Spain.

Insights

The human microbiome significantly impacts infectious diseases in children. This review explores microbiome research for preventing, diagnosing, and treating pediatric infections, highlighting clinical practice integration needs.

Area of Science:

  • Microbiology
  • Immunology
  • Pediatrics

Background:

  • The human microbiome's role in health and disease is increasingly recognized.
  • The interaction between the microbiota and the immune system has profound implications for infectious diseases.
  • Understanding the pediatric microbiome is crucial for addressing infectious disease challenges.

Purpose of the Study:

  • To provide a comprehensive overview of the influence of the microbiome on infectious diseases in children.
  • To summarize current evidence on microbiome research in pediatric infectious disease prevention, diagnosis, and treatment.

Main Methods:

  • Systematic review of existing literature on the pediatric microbiome and infectious diseases.
  • Analysis of findings related to prevention, diagnosis, and treatment strategies.
  • Focus on translating microbiome knowledge into clinical practice.

Main Results:

  • The microbiome plays a significant role in various pediatric infectious diseases.
  • Current research reveals potential applications in disease prevention and diagnosis.
  • Treatment strategies incorporating microbiome modulation show promise.

Conclusions:

  • Significant research gaps remain in understanding the pediatric microbiome's influence on infections.
  • Integrating microbiome-based insights into routine pediatric clinical practice is essential.
  • Further research is needed to fully leverage microbiome knowledge for improved child health outcomes.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
748
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
303
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.3K